Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release

Podobne zapisy

• Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study
  od: Rothschild, Anthony J., i wsp.
  Wydane: (2009)
• Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study
  od: Kornstein, Susan G., i wsp.
  Wydane: (2008)
• Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study
  od: Thase, Michael E., i wsp.
  Wydane: (2011)
• Venlafaxine Extended-Release Treatment of Hoarding Disorder
  od: Saxena, Sanjaya, i wsp.
  Wydane: (2014)
• Chronic forms of major depression are still undertreated in the 21st century: Systematic assessment of 801 patients presenting for treatment
  od: Kocsis, James H., i wsp.
  Wydane: (2008)